AI demand is surging in the usa! Palantir's third-quarter revenue exceeded expectations and raised its full-year performance guidance.
Palantir has raised its full-year revenue outlook to $2.805 billion-2.809 billion, and the company also reported a significant growth in a closely watched indicator: revenue from usa commercial business, which is a key driver of sales growth.
Daily short sale tracking: Viking Therapeutics's short volume increased by 3 million, with a short sale ratio of 14%
Viking Therapeutics(VKTX.US) ranked top of the list had the largest change in short volume (3.8 million shares), and the short volume ratio of Enbridge(ENB.US) reached 58.29%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Express News | Pre-market trading: Palantir surges 13% after earnings, DJT up over 8%, cryptos concept stocks rally collectively.
Express News | Palantir's pre-market trading spread has expanded, now up more than 17%, with Q3 revenue exceeding expectations and the full year performance guidance being raised.
Sector Update: Tech
Trending Tickers: Aramco, Palantir, Trump Media, Schroeders